RA CAPITAL MANAGEMENT, L.P. sold 15.8% of their position (221.17K shares) of VOR BIOPHARMA INC. on the open market
Open‑market sale worth $6.20M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 10/27/2025ACC: 0001231919-25-000359
Director10% Owner
Since Feb 2021
-221.17K
Net shares
Net seller
$6.20M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
221.17K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−76.88K
Price / share
$28.01
Trade value
$2.15M
% of position
5.5%
10/23/2025
1.40M→1.32M
Common Stock
Indirect
Shares
−53.34K
Price / share
$28.01
Trade value
$1.49M
% of position
4.0%
10/24/2025
1.32M→1.27M
Common Stock
Indirect
Shares
−90.94K
Price / share
$28.12
Trade value
$2.56M
% of position
7.2%
10/27/2025
1.27M→1.18M
Total
Net shares
−221.17K
Net value
-$6.20M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/23/2025 | S · Sale | −76.88K | $28.01 | $2.15M | 5.5% | 1.40M | 1.32M |
| Common Stock Indirect | 10/24/2025 | S · Sale | −53.34K | $28.01 | $1.49M | 4.0% | 1.32M | 1.27M |
| Common Stock Indirect | 10/27/2025 | S · Sale | −90.94K | $28.12 | $2.56M | 7.2% | 1.27M | 1.18M |
| Total | −221.17K | -$6.20M | ||||||
Derivative Transactions0
No derivative transactions reported